NCT05482906 Common and Specific Information From Neuroimaging and Smartphone
| NCT ID | NCT05482906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-04-03 |
| Primary Completion | 2026-04-30 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).
Eligibility Criteria
Inclusion Criteria : * Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS) * Over 18 years old /age greater than 18 years * Patients followed at Nantes university hospital or Rennes university hospital * Last known EDSS before inclusion ranging from 0 to 6 inclusive/EDSS of 0 to 6 inclusive, prior inclusion * No relapse within 3 months * With a Medullar MRI planed as part as usual care * MRI scan can be performed within a maximum of 4 months after or before the walking test. * Affiliated person or beneficiary of a social security scheme Exclusion Criteria : * Bilateral aid needed to walk * Women who are pregnant * Patient having expressed their opposition * Patient under guardianship or security measure
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.